Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Marktpuls

Roche Investor Update: FDA approves expanded indication for ACTEMRA® in Rheumatoid Arthritis » Report
Clariant expands production capacity for Houdry® dehydrogenation catalysts » Report
Kühne + Nagel-Gruppe – 9-Monatsergebnis 2012: Positive Ergebnisentwicklung im dritten Quartal » Report
Kuehne + Nagel Group – Nine-months 2012 results: Positive development of results in the third quarter » Report
Addex Therapeutics raises $10 million in a Private Placement to International Institutional Investors » Report
Roche: FDA Approves Expanded Indication for ACTEMRA in Rheumatoid Arthritis » Report
ADB Group reports Swiss Takeover Board decision » Report
Dätwyler vollzieht den Kauf des asiatischen Unternehmensverbunds » Report
IN ZEICHNUNG: JB Barrier Reverse Convertibles » Report
JPMorgan Q3 EPS of $1.40 beats by 19c. Revenue of $25.9B beats by $1400m » Report
SWISS RE NEW SIGMA STUDY - FACING THE INTEREST RATE CHALLENGE » Report
Ernst & Young: IFRS outlook - September 2012 » Report
Credit Suisse: Products in Subscription » Report
Nestlé reaffirms presence in South East Asia with new investment » Report
Dufry to issue U.S. dollar denominated Senior Notes » Report
New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months » Report
Sulzer: Bestellungseingang von CHF 3 Milliarden » Report
Sulzer: CHF 3 Billion in Order Intake » Report
Carlo Gavazzi announces preliminary half year 2012/13 figures » Report
ADB showcases latest innovations at Broadband World Forum 2012 » Report